Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 18 Feb 2026 for Coca-Cola HBC AG. Read the official filing
Filing timeline
BuySaleBarbara Toenz
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
Closed purchases
Market purchases
35
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- -10.3%Entry £47.74 · Close 09 Oct 2026 £42.82
- +10.3%Entry £38.82 · Close 09 Oct 2026 £42.82
- +11.6%Entry £38.38 · Close 09 Oct 2026 £42.82
- +23.3%Entry £34.74 · Close 09 Oct 2026 £42.82
- +19.1%Entry £35.96 · Close 09 Oct 2026 £42.82
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Barbara Toenz: trading record in brief
This profile gathers the share dealings of Barbara Toenz in Coca-Cola HBC AG. Over a trading history stretching from 16 June 2023 to 17 February 2026, the count stands at 38 filings.
Sales make up the whole of the open-market record (1 sale, €869k). Besides market trades, the filings include 37 share grants.
The record was last updated on 18 February 2026 with a share grant in Coca-Cola HBC AG. The median gap between a trade and its publication by RNS (LSE) is 1 day. The legal deadline for notifying a trade is three business days (UK MAR). Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Barbara Toenz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations38 total
0XLONRNS:c6180186-6052-45b4-a644-171ed0251413-7
Canonical exit: 18 May 2026 (T+90)
0XLONRNS:0b7e599b-e57b-4444-848c-34eae4c62517-8
Canonical exit: 16 Apr 2026 (T+90)
0XLONRNS:cf30e649-c5b6-41d8-9999-457b30522a78-8
Canonical exit: 17 Mar 2026 (T+90)
0XLONISIN CH0198251305RNS:5868283-8
Canonical exit: 15 Jan 2026 (T+90)
0XLONISIN CH0198251305RNS:5826797-8
Canonical exit: 16 Dec 2025 (T+90)
0XLONISIN CH0198251305RNS:5786734-8
Canonical exit: 16 Nov 2025 (T+90)
0XLONISIN CH0198251305RNS:5744521-8
Canonical exit: 15 Oct 2025 (T+90)
0XLONISIN CH0198251305RNS:5717857-8
Canonical exit: 25 Sept 2025 (T+90)
0XLONISIN CH0198251305RNS:5701895-8
Canonical exit: 15 Sept 2025 (T+90)
0XLONISIN CH0198251305RNS:5662040-8
Canonical exit: 17 Aug 2025 (T+90)
0XLONISIN CH0198251305RNS:5624543-8
Canonical exit: 16 Jul 2025 (T+90)
21,017 shares@ £34.440746.2% of flowXLONISIN CH0198251305RNS:5595002-13
0XLONISIN CH0198251305RNS:5579070-8
Canonical exit: 15 Jun 2025 (T+90)
12,507 shares@ £34.7627.4% of flowOUTSIDE A TRADING VENUEISIN CH0198251305RNS:5573541-9
0XLONISIN CH0198251305RNS:5543094-8
Canonical exit: 18 May 2025 (T+90)
0XLONISIN CH0198251305RNS:5507401-8
Canonical exit: 17 Apr 2025 (T+90)
0XLONISIN CH0198251305RNS:5473739-8
Canonical exit: 17 Mar 2025 (T+90)
0XLONISIN CH0198251305RNS:5435925-8
Canonical exit: 16 Feb 2025 (T+90)
0XLONISIN CH0198251305RNS:5395747-8
Canonical exit: 15 Jan 2025 (T+90)
0XLONISIN CH0198251305RNS:5354865-8
Canonical exit: 16 Dec 2024 (T+90)
0XLONISIN CH0198251305RNS:5314553-8
Canonical exit: 14 Nov 2024 (T+90)
0XLONISIN CH0198251305RNS:5272344-8
Canonical exit: 15 Oct 2024 (T+90)
0XLONISIN CH0198251305RNS:5245105-8
Canonical exit: 25 Sept 2024 (T+90)
0XLONISIN CH0198251305RNS:5229733-8
Canonical exit: 15 Sept 2024 (T+90)
0XLONISIN CH0198251305RNS:5190364-8
Canonical exit: 15 Aug 2024 (T+90)
25 of 38 declarations
